Ibogaine treatment for San Diego residents: the physician-prescribed pathway through Brazil

Ibogaine is a Schedule I controlled substance in the United States. No clinic, hospital, or physician in California can legally prescribe or administer it. That policy gap is not closing soon, even as Sacramento has taken meaningful steps to enable research.

In October 2025, Governor Gavin Newsom signed AB 1103 (Chapter 571), authored by Assemblymember Christopher Ward (D-San Diego) — a district with one of the largest concentrations of military personnel in the country. The bill streamlines the state Research Advisory Panel's review of federally authorized clinical studies involving Schedule I and II substances, including ibogaine. It took effect January 1, 2026. It enables research, not treatment. No California resident can legally receive ibogaine inside the United States as of June 2026.

San Diego County's overdose trajectory makes the stakes visible. Deaths peaked at 1,309 in 2021 before falling to 945 in 2024 — three consecutive years of decline, driven in part by naloxone distribution and the county's "one pill can kill" public education campaigns. Fentanyl and methamphetamine remain at the center: 494 fentanyl deaths and 600 methamphetamine deaths in 2024, with polysubstance use the norm.

San Diego's border proximity adds a layer many families navigate carefully. Tijuana is minutes away, and ibogaine clinics operate across the border in Mexico. But proximity does not change federal law — and the regulatory framework in Mexico is not equivalent to Brazil's ANVISA-approved hospital infrastructure. For San Diego families who need physician oversight, cardiac telemetry, and hospital emergency capability, the physician-prescribed pathway runs through Brazil.

If your loved one is in active addiction, you have probably heard a lot of clinical language that did not translate into results. Ibogaine is worth understanding differently, because it works differently.

Ibogaine is a naturally occurring compound derived from the root bark of the iboga plant. It acts on multiple receptor systems simultaneously, including opioid receptors, NMDA receptors, and serotonin pathways. The result, for many patients, is a dramatic reduction in acute opioid withdrawal symptoms and a reset of the neurological patterns that drive compulsive use. The full receptor-level mechanism is covered in detail on our ibogaine overview.

What makes ibogaine different from medication-assisted treatment goes beyond pharmacology. It is the window that opens after. In the weeks following a session, the brain enters a period of elevated neuroplasticity, sometimes called the Window of Wonder, that typically lasts 2 to 12 weeks. This is not a passive recovery period. It is the window that Nekawa's 15-day on-site integration and 45-day at-home coursework are specifically built around, because what a student does during that window shapes what the session becomes long-term.

Ibogaine is not appropriate for everyone. The peer-reviewed research is serious and growing, and so is the understanding of who is and is not a candidate. Cardiac history, current medications, and other health factors all matter. That is precisely why the physician-prescribed pathway requires a full medical workup before any session proceeds.

The ibogaine session at the heart of Nekawa's program is prescribed and administered by independent licensed Brazilian physicians, not by Nekawa. Understanding what that means in practice matters, because it is the difference between a supervised medical procedure and an unmonitored retreat experience.

Before the prescribing physicians clear a patient for ibogaine, the workup includes:

• EKG
• QT-interval check
• Comprehensive blood panel
• Liver function test
• Magnesium loading

The QT-interval check is the critical cardiac screen. Ibogaine affects cardiac conduction, and a prolonged QT interval is a contraindication. This is not a formality. It is the reason the medical workup exists.

During the session, an on-site physician is present throughout. The hospital's ICU-trained nursing team monitors continuous cardiac telemetry for a minimum of 24 hours post-dose. The session itself moves through distinct phases: the intense visionary phase lasts 6 to 12 hours, followed by roughly 12 hours of quieter mental processing, then 24 to 48 hours of physical recuperation.

Nekawa's role is not clinical. We build the preparation, the environment, and the integration structure around the medical team's work. The full program structure is:

• 10 days of preparation and on-site medical onboarding before the session
• The ibogaine session, administered by the medical team in a hospital setting with continuous cardiac telemetry
• 15 days of structured integration on the property
• 45 days of at-home integration coursework after returning home

Longer on-site programs of up to 90 days are available for students who want deeper transformation work. The 28-day structure is the foundation; the extended program builds on it.

See our cardiac safety overview for the full QT-interval, EKG, and screening protocol the prescribing physicians follow.

Mexico and Costa Rica have become common destinations for ibogaine, and for San Diego residents, Mexico is geographically close. Some of the programs there are run by serious people. But the regulatory framework is not the same, and that difference matters when you are talking about a compound that requires continuous cardiac monitoring.

In Brazil, ibogaine is approved for medical use under ANVISA, Brazil's federal health agency, the equivalent of the FDA. Treatment is prescribed by licensed physicians and delivered within hospital infrastructure that includes emergency response capability. This is not a private villa. It is not a retreat center operating in a gray area. The current US and global legal status of ibogaine makes clear why the structure of the Brazilian system is distinct.

Nekawa is a wellness education academy, structured around the hospital infrastructure that physician-administered ibogaine treatment requires. We do not run the medical protocol. The prescribing physicians do. What we provide is the preparation curriculum, the environment, the integration coursework, and the program structure that gives the medical session its full context.

The distinction matters for San Diego students specifically. Border proximity makes Mexico the obvious first thought — but hospital-administered ibogaine with continuous cardiac telemetry is a different category of care than what most cross-border programs provide. That is what the Brazilian pathway offers, and it is what California's research legislation is designed to study.

San Diego International (SAN) connects to São Paulo–Guarulhos (GRU) or Rio de Janeiro–Galeão (GIG) via one-stop service through Los Angeles, Houston, or Atlanta. Total travel time typically runs 14 to 18 hours door to door, depending on connection length.

From either GRU or GIG, it is a 4-hour drive along the BR-101 coastal highway to Paraty, on Brazil's Costa Verde coast. We arrange private ground transport from the airport, so students arrive directly without navigating Brazilian transit or making connections.

What you arrive to is not a medical facility. Our location sits in the Atlantic rainforest, the Mata Atlântica, at the edge of the sea. Old-growth jungle. Waterfalls. A protected lagoon. A bay scattered with more than 300 forested islands. The colonial port town of Paraty is just outside. The environment is part of the program. The preparation and integration work we walk students through is designed to use the setting intentionally.

As of January 1, 2026, US travelers need an approved Brazilian eVisa to enter Brazil. Apply online at brazil.vfsevisa.com.

• Cost: US$80.90
• Processing time: about 72 hours
• Validity: 10 years, multiple entries of up to 90 days per stay
• Passport: US passport with at least 6 months of remaining validity

Our intake team walks every student through this during onboarding.

California is among the most active states in ibogaine policy — but active does not mean accessible.

AB 1103, signed in October 2025 and authored by San Diego's Christopher Ward, streamlines the Research Advisory Panel review process for FDA-authorized studies involving Schedule I and II substances. AB 2489 further authorizes the panel to submit FDA applications for multisite clinical trials of ibogaine among veteran subjects with suicidality-related comorbidities. The April 2026 Executive Order on ibogaine research — with a specific focus on veterans — matters deeply in San Diego, home to Naval Base San Diego, Marine Corps Air Station Miramar, and Camp Pendleton.

This is meaningful policy. California's posture is research-enabling rather than research-funding — unlike Texas's $50 million SB 2308 program. But clinical trial streamlining is not treatment access. A San Diego resident in active addiction in June 2026 cannot receive ibogaine in California, cannot enroll in a trial as a treatment pathway yet, and has no domestic medical provider to turn to for it.

San Diego County's harm-reduction investments — naloxone kits, fentanyl test strips, the SUOPT task force — have contributed to three consecutive years of declining overdose deaths. Those public health gains are real. They do not create ibogaine treatment access. California recorded 7,385 provisional drug overdose deaths in 2024 per CDC NCHS data. For now, the physician-prescribed pathway runs through Brazil.

The ibogaine session is not the end of the program. It is closer to the beginning of the part that requires the most work.

The 45 days of at-home integration coursework that follow the on-site program are structured around the Window of Wonder, the 2 to 12 weeks of elevated neuroplasticity that follow the session. This is when the brain is most receptive to new patterns, and it is when the coursework is designed to be used. Students returning to San Diego — to a condo in Pacific Beach, a house in North Park, or an apartment in Hillcrest — return to the same environment where the patterns formed. The at-home coursework is built with that reality in mind, including the social networks, economic stressors, and triggers that make recovery in this city its own challenge.

San Diego County's expanded naloxone distribution and overdose prevention campaigns have contributed to declining deaths — including zero overdose deaths among people under 18 in 2024. Integration is the complement on the other side of a medical session: structured reflection, specific practices, and ongoing engagement with the material from the preparation phase. Our team remains in contact with students through this period. The work continues.

For students with opioid dependence specifically, the opioid program page covers how the full curriculum is structured for that context. Students navigating burnout, depression, or anxiety alongside addiction may find the burnout and mental health program relevant as well.

The first step is a discovery call. This is a candidacy and program-fit conversation, not a sales call. We are looking at whether Nekawa's program is genuinely right for you or your loved one, and whether you are ready to do what the program requires.

On the call, we cover the program structure, the preparation curriculum, what the on-site experience involves, and what the at-home integration period looks like. We also talk honestly about who the program is not right for. Clinical screening is conducted separately by the prescribing physicians. What we assess is program fit, commitment, and readiness.

If the program is a fit, we move to intake, onboarding, and scheduling. Our intake team handles visa guidance, ground transport coordination, and preparation coursework. You do not navigate this alone.

To start, visit Book a discovery call. If you are a San Diego family member trying to understand whether this is the right path, the discovery call is the right place to begin.